The Innovative Licensing and Access Pathway (ILAP) launched in the UK in January this year is proving popular, with 67 applications received so far for an innovation passport, a designation that allows innovative medicines access to the new pathway.
ILAP is intended to offer a more integrated approach to drug development and access by involving several bodies including the...








